| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | See Remarks | Chief Executive Office
1 company
Anderson Michael S is a Chief Executive Officer at AVADEL PHARMACEUTICALS PLC. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 5,000 | $11.04 | $55,220.00 | +4.0% | |
| Mar 14, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Office | Buy | 10,000 | $9.74 | $97,350.00 | +8.8% |